TMO
Thermo Fisher Scientific Inc.
- Net income, 2025
- $6.7B
- YoY, 2025
- +5.8%
- 5-year CAGR
- +1.0%
- 10-year CAGR
- +13.0%
Net income
Net income by fiscal year
| Period | Net income | YoY |
|---|---|---|
| 2025 | $6.7B | +5.8% |
| 2024 | $6.3B | +5.7% |
| 2023 | $6.0B | −13.7% |
| 2022 | $7.0B | −10.0% |
| 2021 | $7.7B | +21.2% |
| 2020 | $6.4B | +72.5% |
| 2019 | $3.7B | +25.8% |
| 2018 | $2.9B | +32.0% |
| 2017 | $2.2B | +10.0% |
| 2016 | $2.0B | +2.4% |
| 2015 | $2.0B | +4.3% |
| 2014 | $1.9B | +48.8% |
| 2013 | $1.3B | +8.1% |
| 2012 | $1.2B | −11.4% |
| 2011 | $1.3B | +28.4% |
| 2010 | $1.0B | +21.8% |
| 2009 | $850M | −13.3% |
| 2008 | $981M | +31.1% |
| 2007 | $748M | — |